http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101080581-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101080581-B1 |
| titleOfInvention | Magnetic Resonance Imaging T1 and T2 Dual Contrast Iron Oxide / Manganese Oxide Hybrid Nanoparticles and Method for Preparing the Same |
| abstract | The present invention relates to iron oxide / manganese oxide hybrid nanoparticles having a T1 and T2 double contrast action and a method for preparing the same. The dumbbell-type iron oxide / manganese oxide hybrid nanoparticles can enhance cancer signals in blood vessels and liver in T2-weighted MRI, while simultaneously enhancing light signals in brain and kidney in T1-weighted MRI. Thus, for both T1 and T2 weighted bioimaging, it can be used as an MRI contrast agent capable of inducing organ specific contrast enhancement.n n n n Magnetic Resonance Imaging, Nanoparticles, Double Contrast, T1 Contrast, T2 Contrast |
| priorityDate | 2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.